Petra M. Meiners

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome.

Attenuation of Follicular Helper T Cell-Dependent B Cell Hyperactivity by Abatacept Treatment in Primary Sjögren's Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 22, 2017

Detailed Analysis of the Articular Domain in Patients with Primary Sjögren Syndrome.

Detailed Analysis of the Articular Domain in Patients with Primary Sjögren Syndrome.

Journal: The Journal of rheumatology
Published: November 16, 2016

B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.

B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.

Journal: The Journal of rheumatology
Published: October 18, 2016

Physical fatigue characterises patient experience of primary Sjögren's syndrome.

Physical fatigue characterises patient experience of primary Sjögren's syndrome.

Journal: Clinical and experimental rheumatology
Published: June 24, 2016

Abatacept treatment of patients with primary Sjögren's syndrome results in a decrease of germinal centres in salivary gland tissue.

Abatacept treatment of patients with primary Sjögren's syndrome results in a decrease of germinal centres in salivary gland tissue.

Journal: Clinical and experimental rheumatology
Published: May 26, 2016

Dental Implants in Patients with Sjögren's Syndrome.

Dental Implants in Patients with Sjögren's Syndrome.

Journal: Clinical implant dentistry and related research
Published: September 25, 2015

Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies.

Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies.

Journal: Annals of the rheumatic diseases
Published: August 31, 2015

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Journal: RMD open
Published: November 21, 2014

Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.

Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.

Journal: Rheumatology (Oxford, England)
Published: October 13, 2014

Efficacy of retreatment with rituximab in patients with primary Sjögren's syndrome.

Efficacy of retreatment with rituximab in patients with primary Sjögren's syndrome.

Journal: Clinical and experimental rheumatology
Published: October 02, 2014

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

Journal: Annals of the rheumatic diseases
Published: May 30, 2014

Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).

Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).

Journal: Annals of the rheumatic diseases
Published: January 30, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026